AMBOSS has processes in place to ensure that all CME content it provides is independent and free of bias from any commercial interests. These processes are in compliance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education, and are conducted in the following order.
1. Identification of financial relationships
- All individuals who have any element of control over CME content are required to disclose information annually about all financial relationships with ineligible companies in the past 24 months.
- The nature of the relationship and the name of the ineligible company must be disclosed.
- Relationships must be disclosed regardless of the amount involved.
- An ineligible company, previously known as a commercial interest, is defined as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. (Examples include medical device manufacturers, pharmaceutical companies, and advertising, marketing, or communication firms whose clients are ineligible companies.)
- This information is collected on a standardized form, and all forms are maintained on file.
- Individuals who decline to disclose this information are not permitted to be involved with any aspect of CME content.
2. Exclusion of owners or employees of ineligible companies
Individuals who own or are employed by an ineligible company are prohibited from having control over or involvement with any aspect of AMBOSS CME content, unless the CME content has no relation to the business lines or products of their employer/company.
3. Identification and mitigation of COIs
- Disclosures are reviewed to determine whether an individual has a financial relationship that is relevant to the CME content over which the individual has control.
- For CME planners (including the Chief Medical Officer, Editor-in-Chief, and Content Leads): Active COIs are not permitted. If identified, they are required to be divested.
- For individuals in all other CME roles (including authors and editors): If a COI is identified, it is evaluated and appropriately mitigated, e.g., by peer review (with modification of content if necessary) by a non-conflicted individual or divestiture of the relationship.
4. Disclosure of COIs
- Disclosures of the existence or non-existence of conflicts of interestfor all content contributors are displayed in the topmost section of each CME topic article.
- Where a relevant financial relationship exists, the name of the individual, the name of the ineligible company, and the nature of the relationship is disclosed.
For questions or feedback related to the AMBOSS CME program, please email us at email@example.com.